Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden ; volume:6 ; number:1 ; day:9 ; month:5 ; year:2018 ; pages:1-12 ; date:12.2018
Journal for ImmunoTherapy of Cancer ; 6, Heft 1 (9.5.2018), 1-12, 12.2018
- Urheber
-
Morrison, Carl
- Beteiligte Personen und Organisationen
-
Pabla, Sarabjot
Conroy, Jeffrey M.
Nesline, Mary K.
Glenn, Sean T.
Dressman, Devin
Papanicolau-Sengos, Antonios
Burgher, Blake
Andreas, Jonathan
Giamo, Vincent
Qin, Moachun
Wang, Yirong
Lenzo, Felicia L.
Omilian, Angela
Bshara, Wiam
Zibelman, Matthew
Ghatalia, Pooja
Dragnev, Konstantin
Shirai, Keisuke
Madden, Katherine G.
Tafe, Laura J.
Shah, Neel
Kasuganti, Deepa
de la Cruz-Merino, Luis
Araujo, Isabel
Saenger, Yvonne
Bogardus, Margaret
Villalona-Calero, Miguel
Diaz, Zuanel
Day, Roger
Eisenberg, Marcia
Anderson, Steven M.
Puzanov, Igor
Galluzzi, Lorenzo
Gardner, Mark
Ernstoff, Marc S.
SpringerLink (Online service)
- DOI
-
10.1186/s40425-018-0344-8
- URN
-
urn:nbn:de:101:1-2018072917040983738546
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Morrison, Carl
- Pabla, Sarabjot
- Conroy, Jeffrey M.
- Nesline, Mary K.
- Glenn, Sean T.
- Dressman, Devin
- Papanicolau-Sengos, Antonios
- Burgher, Blake
- Andreas, Jonathan
- Giamo, Vincent
- Qin, Moachun
- Wang, Yirong
- Lenzo, Felicia L.
- Omilian, Angela
- Bshara, Wiam
- Zibelman, Matthew
- Ghatalia, Pooja
- Dragnev, Konstantin
- Shirai, Keisuke
- Madden, Katherine G.
- Tafe, Laura J.
- Shah, Neel
- Kasuganti, Deepa
- de la Cruz-Merino, Luis
- Araujo, Isabel
- Saenger, Yvonne
- Bogardus, Margaret
- Villalona-Calero, Miguel
- Diaz, Zuanel
- Day, Roger
- Eisenberg, Marcia
- Anderson, Steven M.
- Puzanov, Igor
- Galluzzi, Lorenzo
- Gardner, Mark
- Ernstoff, Marc S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma
Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma
Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization
Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma
Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma
Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization
Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma
Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma
Distinct antibody clones detect PD-1 checkpoint expression and block PD-L1 interactions on live murine melanoma cells
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization
Optochemical Control of Immune Checkpoint Blockade via Light‐Triggered PD‐L1 Dimerization
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression